Developing a cost-effective imaging strategy, fully integrated into a broader clinical development process, requires specific knowledge of regulatory requirements and ever-changing industry trends. Our consulting services are lead by a team with over 25 combined years experience in the use of medical imaging in clinical trials. Additional world-class imaging consulting expertise is available through the worldwide RadMD network of over 600 physicians and imaging medical physicists.

When independent image evaluations (“blinded reads”) are used in trials, it is critical that physicians performing the evaluations have expertise in the disease process. Our blinded reader sourcing service matches the most qualified physicians to individual studies, with the largest global network of physicians who have undergone standardized training as blinded readers. This translates into faster image evaluations by the most qualified personnel for your trials.
In the News
MARCH 10, 2015
RSNA 2014 Abstract: Evaluation of a New Manganese-based Orally-Administered Hepatobiliary MR Contrast Agent
read more
MARCH 09, 2015
RadMD Presents at ECR 2015: Comparison of a New Manganese-Based Orally-Administered Hepatobiliary MR Contrast Agent with Gd-Chelate-enhanced MR Images for the Evaluation of Focal Liver Lesions
read more
OCTOBER 14, 2014
Rick Patt, M.D. as Session Moderator at the 2014 Translational Imaging Symposium in Boston, MA
read more
SEPTEMBER 24, 2014
RadMD Presents at Society of Computed Body Tomography and Magnetic Resonance Annual Meeting in New Orleans, LA & RSNA Annual Meeting in Chicago, IL
read more
Who We Are Services BRITI News Contact Us
Consulting Sourcing BRITI